AC
ETON icon

Aristides Capital’s Eton Pharmaceutcials ETON Stock Holding History

Aristides Capital’s Portfolio ETON Stock Details ETON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.59M Buy
186,041
+24,605
+15% +$430K 0.99% 26
2025
Q4 		$2.73M Sell
161,436
-6,151
-4% -$108K 0.48% 43
2025
Q3 		$3.64M Hold
167,587
– – 0.53% 38
2025
Q2 		$2.39M Sell
167,587
-74,000
-31% -$1.17M 0.47% 38
2025
Q1 		$3.14M Hold
241,587
– – 0.93% 29
2024
Q4 		$3.22M Buy
241,587
+41,587
+21% +$422K 0.66% 28
2024
Q3 		$1.2M Hold
200,000
– – 0.37% 60
2024
Q2 		$658K Buy
+200,000
New +$700K 0.19% 99

Other funds holding ETON

OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Aristides Capital's ETON Position: Q1 2026 in Review

Aristides Capital increased its Eton Pharmaceutcials (ETON) stake by 15% in Q1 2026, buying an estimated $430K and bringing the position to 186,041 shares worth $4.59M. The position accounts for 0.99% of the portfolio, ranked #26.

Aristides Capital first reported a position in ETON in Q2 2024 and has held it in 8 quarters since. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Aristides Capital held 186,041 shares of Eton Pharmaceutcials worth $4.59M as of Q1 2026.
  • Aristides Capital bought 24,605 Eton Pharmaceutcials shares in Q1 2026, an estimated $430K.
  • Eton Pharmaceutcials made up 0.99% of Aristides Capital's portfolio in Q1 2026, its #26 holding.
  • Aristides Capital first reported a position in Eton Pharmaceutcials in Q2 2024 and has held it in 8 quarters since.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Aristides Capital's 13F filing for Q1 2026, filed 14 May 2026.